Table 2.
Study | Parameter | Group | Pre | Challenge | Room-air |
---|---|---|---|---|---|
Hypoxia | ΔfR, breaths/min | SHAM | 104 ± 6 | −56 ± 16a | −160 ± 21a |
CSNX | 98 ± 2 | −46 ± 14a | +5 ± 18b | ||
ΔVt, ml | SHAM | 1.58 ± 0.10 | +16.3 ±1.6 | +4.0 ± 0.8 | |
CSNX | 1.25 ± 0.08 | 8.7 ± l.la | −19 ± 5b | ||
ΔVe, ml/min | SHAM | 250 ± 26 | 163 ± 11 | −35 ± 4b | |
CSNX | 210 ± 27 | 123 ± 7a | −41 ± 5b | ||
ΔTI, sec | SHAM | 0.17 ±0.01 | 0.29 ± 0.01 | +74 ± 6b | |
CSNX | 0.18 ±0.02 | 0.31 ± 0.01 | +85 ±llb | ||
ΔVt/Ti, ml/sec | SHAM | 12.0 ±1.0 | 5.5 ± 0.4 | −54 ± 2b | |
CSNX | 10.0 ±1.0 | 4.0 ± 0.2a | −59 ± 3b | ||
Hypercapnia | ΔfR, breaths/min | SHAM | 100 ± 5 | 110 ± 3 | +11 ± 7 |
CSNX | 101 ± 3 | 111 ±5 | +9± 2b | ||
ΔVt, ml | SHAM | 2.35 ± 0.10 | 1.94 ± 0.03 | −17 ± 3b | |
CSNX | 2.16 ± 0.10 | 1.63 ± 0.05a | −19 ± 5b | ||
ΔVe, ml/min | SHAM | 233 ± 6 | 214 ±8 | −8±3b | |
CSNX | 218 ± 13 | 180 ±8 | −17 ± 6b | ||
ΔTi, sec | SHAM | 0.20 ±0.01 | 0.28 ±0.01 | +40 ± 3b | |
CSNX | 0.21 ±0.01 | 0.26 ±0.02 | +26 ± 3b,c | ||
ΔVt/Ti, ml/sec | SHAM | 11.8 ±0.6 | 7.0 ±0.2 | −41 ± 2b | |
CSNX | 10.6 ± 1.0 | 6.3 ±0.6 | −39 ± 5b |
The data are presented as mean ± S.E.M. SHAM, sham-operated rats. CSNX, carotid sinus nerve-transected rats. fR, frequency. Vt, tidal volume. Ve, minute ventilation. TI, inspiratory time. Vt/Ti, tidal/volume/inspiratory time. There were 6 rats in each group.
P < 0.05, post-morphine CSNX rats versus post-morphine SHAM rats.
P < 0.05, significant %change from post-morphine.
P < 0.05, morphine response in CSNX rats versus morphine response in SHAM rats.